OMass Therapeutics
OMass has developed the OdyssION™ platform to allow for the interrogation of individual targets in the context of the native ecosystem, while avoiding the confounding complexity of the cell. By distilling biology to its essential elements, the OMass approach facilitates the search for new drugs against previously intractable targets and enables an impressive portfolio of therapeutic programs to improve the lives of patients with immunological and rare diseases.